Patient Seminar Program
Co chairs, Ate van der Zee, Immediate Past President, ESGO & Louise Bayne, CEO Ovacome UK, opening the ESGO Patient Seminar
Ate van der Zee, Immediate Past President, ESGO introducing gynaecological cancers.
John Butler, International Cancer Benchmarking Partnership, Gynaecological Oncology Fellow St Bartholomews and Royal Marsden Hospital, UK talking about the inequalities in survival of gynaecological cancers in Europe today.
Ate van der Zee, Immediate Past President, ESGO talking to ESGO Patient Seminar participants.
From left to right : Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO ; Louise Bayne, CEO, Ovacome UK and Jan Geissler, CEO Patvocates and Co-Founder CML Advocates Network.
ESGO Patient Seminar Participants enjoying a coffee break.
Session speakers during the Q & A. From left to right: Flavia Bideri, ACTO onlus, Italy (Patient Participation in Research) ; Jalid Sehouli, Charité Universitätsmedizin Berlin, Germany (Current options and the ongoing future of clinical trials) ; Emma Elliot, National Forum of Gynaecological Oncology Nurses, UK (Multidisciplinary treatment in gynaecological cancer) and Frederic Amant, UZ Gasthuisberg/Katholieke Universiteit Leuven, Belgium (Innovation, target therapies and individualised medicine)
Louise Bayne, CEO Ovacome, UK, speaking about their leading initiatives in Ovarian cancer.
Doris Schmitt, PATH, Germany presenting the Patient-driven breast cancer tumour bank as a possible model for gynaecological cancers.